Andrew D. Kelly

954 total citations
23 papers, 658 citations indexed

About

Andrew D. Kelly is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrew D. Kelly has authored 23 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 11 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrew D. Kelly's work include Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (8 papers) and Acute Myeloid Leukemia Research (5 papers). Andrew D. Kelly is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (8 papers) and Acute Myeloid Leukemia Research (5 papers). Andrew D. Kelly collaborates with scholars based in United States, Australia and Canada. Andrew D. Kelly's co-authors include Jean‐Pierre J. Issa, Dimitrios Spentzos, Jaroslav Jelı́nek, Jeffrey D. Goldsmith, Bela Patel, Charly R. Good, Jozef Madžo, Shoghag Panjarian, Susanne B. Breitkopf and John M. Asara and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Andrew D. Kelly

22 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew D. Kelly United States 11 502 253 120 79 40 23 658
Gerben Duns Canada 10 463 0.9× 218 0.9× 140 1.2× 73 0.9× 23 0.6× 22 619
Caroline Paccard France 9 361 0.7× 213 0.8× 48 0.4× 109 1.4× 38 0.9× 16 541
Bingjian Lü China 15 724 1.4× 408 1.6× 83 0.7× 149 1.9× 65 1.6× 29 921
Maïa Chanrion France 7 513 1.0× 196 0.8× 86 0.7× 231 2.9× 69 1.7× 9 751
Woo-Hee Jung South Korea 14 298 0.6× 377 1.5× 62 0.5× 207 2.6× 22 0.6× 22 648
Brunella Pilato Italy 18 488 1.0× 302 1.2× 87 0.7× 172 2.2× 180 4.5× 46 810
Shereen Metias Canada 8 328 0.7× 236 0.9× 148 1.2× 68 0.9× 11 0.3× 8 475
Alf Spitschak Germany 16 465 0.9× 243 1.0× 67 0.6× 244 3.1× 29 0.7× 24 694
Zahra Mohammed United Kingdom 12 243 0.5× 208 0.8× 70 0.6× 283 3.6× 34 0.8× 18 619
Michelle Bisceglia United States 5 359 0.7× 139 0.5× 393 3.3× 92 1.2× 37 0.9× 7 718

Countries citing papers authored by Andrew D. Kelly

Since Specialization
Citations

This map shows the geographic impact of Andrew D. Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Kelly more than expected).

Fields of papers citing papers by Andrew D. Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Kelly. The network helps show where Andrew D. Kelly may publish in the future.

Co-authorship network of co-authors of Andrew D. Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Kelly. A scholar is included among the top collaborators of Andrew D. Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Kelly. Andrew D. Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slomovitz, Brian M., Natalie Danziger, Júlia C.F. Quintanilha, et al.. (2025). Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer. International Journal of Gynecological Cancer. 35(10). 102107–102107. 1 indexed citations
2.
Lietz, Christopher B., Erik T. Newman, Andrew D. Kelly, et al.. (2022). Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma. Communications Biology. 5(1). 213–213. 25 indexed citations
3.
Kelly, Andrew D., Karthikeyan Murugesan, Meagan Montesion, et al.. (2021). Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response. Journal for ImmunoTherapy of Cancer. 9(11). e003550–e003550. 10 indexed citations
4.
Kelly, Andrew D., Tom Wiklund, Juha Kononen, & James Creeden. (2021). STRN-ALK Fusion–Positive Case of Breast Cancer With Response to Alectinib. JCO Precision Oncology. 5(5). 1281–1284. 3 indexed citations
5.
Antonarakis, Emmanuel S., Zheng Kuang, Hanna Tukachinsky, et al.. (2021). Prevalence of inferred clonal hematopoiesis (CH) detected on comprehensive genomic profiling (CGP) of solid tumor tissue or circulating tumor DNA (ctDNA).. Journal of Clinical Oncology. 39(15_suppl). 3009–3009. 9 indexed citations
6.
Chung, Woonbok, Andrew D. Kelly, Patricia Kropf, et al.. (2019). Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia. Clinical Epigenetics. 11(1). 106–106. 20 indexed citations
7.
Good, Charly R., Shoghag Panjarian, Andrew D. Kelly, et al.. (2018). TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. Cancer Research. 78(15). 4126–4137. 108 indexed citations
8.
Kelly, Andrew D., Jozef Madžo, Priyanka Madireddi, et al.. (2018). Demethylator phenotypes in acute myeloid leukemia. Leukemia. 32(10). 2178–2188. 7 indexed citations
9.
Kelly, Andrew D. & Jean‐Pierre J. Issa. (2017). The promise of epigenetic therapy: reprogramming the cancer epigenome. Current Opinion in Genetics & Development. 42. 68–77. 118 indexed citations
10.
Hill, Katherine E., Andrew D. Kelly, Marieke L. Kuijjer, et al.. (2017). An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets. Journal of Hematology & Oncology. 10(1). 107–107. 28 indexed citations
11.
Kelly, Andrew D., Heike Kroeger, Jumpei Yamazaki, et al.. (2017). A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome. Leukemia. 31(10). 2011–2019. 33 indexed citations
12.
Kelly, Andrew D., et al.. (2017). Epigenetics and Precision Oncology. The Cancer Journal. 23(5). 262–269. 68 indexed citations
13.
Osaka, Eiji, Andrew D. Kelly, Dimitrios Spentzos, et al.. (2015). MicroRNA-155 expression is independently predictive of outcome in chordoma. Oncotarget. 6(11). 9125–9139. 29 indexed citations
14.
Kelly, Andrew D., Benjamin Haibe‐Kains, Katherine A. Janeway, et al.. (2013). MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32. Genome Medicine. 5(1). 2–2. 89 indexed citations
15.
Kelly, Andrew D., Katherine E. Hill, Mick Correll, et al.. (2013). Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: Preliminary assessment of cross-platform concordance. Genomics. 102(1). 8–14. 23 indexed citations
16.
Fountzilas, Elena, Andrew D. Kelly, Antonio R. Pérez‐Atayde, et al.. (2012). A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study. BMC Genomics. 13(1). 332–332. 4 indexed citations
17.
Kelly, Andrew D., Susanne B. Breitkopf, Min Yuan, et al.. (2011). Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma. PLoS ONE. 6(10). e25357–e25357. 59 indexed citations
18.
Kelly, Andrew D., et al.. (1998). Optimizing compilation of CLP( ℛ ). ACM Transactions on Programming Languages and Systems. 20(6). 1223–1250. 7 indexed citations
19.
Kelly, Andrew D., et al.. (1997). A generic object-oriented incremental analyser for constraint logic programs. 1 indexed citations
20.
Kelly, Andrew D., et al.. (1996). Effectiveness of Optimizing Compilation for CLP(R).. 37–51. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerben Duns Breakdown of academic impact, for papers by Caroline Paccard Breakdown of academic impact, for papers by Bingjian Lü Breakdown of academic impact, for papers by Maïa Chanrion Breakdown of academic impact, for papers by Woo-Hee Jung Breakdown of academic impact, for papers by Brunella Pilato Breakdown of academic impact, for papers by Shereen Metias Breakdown of academic impact, for papers by Alf Spitschak Breakdown of academic impact, for papers by Zahra Mohammed Breakdown of academic impact, for papers by Michelle Bisceglia
Rankless by CCL
2026